Anaptysbio Stock Market Value
| ANAB Stock | USD 24.96 0.16 0.64% |
| Symbol | AnaptysBio |
AnaptysBio Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AnaptysBio. If investors know AnaptysBio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AnaptysBio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.05) | Revenue Per Share 2.086 | Quarterly Revenue Growth 8.047 | Return On Assets (0.18) | Return On Equity (1.62) |
The market value of AnaptysBio is measured differently than its book value, which is the value of AnaptysBio that is recorded on the company's balance sheet. Investors also form their own opinion of AnaptysBio's value that differs from its market value or its book value, called intrinsic value, which is AnaptysBio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AnaptysBio's market value can be influenced by many factors that don't directly affect AnaptysBio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AnaptysBio's value and its price as these two are different measures arrived at by different means. Investors typically determine if AnaptysBio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AnaptysBio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
AnaptysBio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AnaptysBio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AnaptysBio.
| 11/01/2024 |
| 12/01/2024 |
If you would invest 0.00 in AnaptysBio on November 1, 2024 and sell it all today you would earn a total of 0.00 from holding AnaptysBio or generate 0.0% return on investment in AnaptysBio over 30 days. AnaptysBio is related to or competes with Crinetics Pharmaceuticals, Rhythm Pharmaceuticals, Kura Oncology, and CytomX Therapeutics. AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for infla... More
AnaptysBio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AnaptysBio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AnaptysBio upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 35.57 | |||
| Value At Risk | (7.28) | |||
| Potential Upside | 5.77 |
AnaptysBio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for AnaptysBio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AnaptysBio's standard deviation. In reality, there are many statistical measures that can use AnaptysBio historical prices to predict the future AnaptysBio's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.86) | |||
| Total Risk Alpha | (1.32) | |||
| Treynor Ratio | (0.14) |
AnaptysBio Backtested Returns
AnaptysBio secures Sharpe Ratio (or Efficiency) of -0.0802, which signifies that the company had a -0.0802% return per unit of standard deviation over the last 3 months. AnaptysBio exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AnaptysBio's mean deviation of 3.46, and Risk Adjusted Performance of (0.05) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 3.21, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, AnaptysBio will likely underperform. At this point, AnaptysBio has a negative expected return of -0.42%. Please make sure to confirm AnaptysBio's total risk alpha, potential upside, and the relationship between the standard deviation and maximum drawdown , to decide if AnaptysBio performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.18 |
Very weak predictability
AnaptysBio has very weak predictability. Overlapping area represents the amount of predictability between AnaptysBio time series from 1st of November 2024 to 16th of November 2024 and 16th of November 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AnaptysBio price movement. The serial correlation of 0.18 indicates that over 18.0% of current AnaptysBio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.18 | |
| Spearman Rank Test | -0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 5.48 |
AnaptysBio lagged returns against current returns
Autocorrelation, which is AnaptysBio stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting AnaptysBio's stock expected returns. We can calculate the autocorrelation of AnaptysBio returns to help us make a trade decision. For example, suppose you find that AnaptysBio has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
AnaptysBio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If AnaptysBio stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if AnaptysBio stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in AnaptysBio stock over time.
Current vs Lagged Prices |
| Timeline |
AnaptysBio Lagged Returns
When evaluating AnaptysBio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of AnaptysBio stock have on its future price. AnaptysBio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, AnaptysBio autocorrelation shows the relationship between AnaptysBio stock current value and its past values and can show if there is a momentum factor associated with investing in AnaptysBio.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether AnaptysBio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AnaptysBio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Anaptysbio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Anaptysbio Stock:Check out AnaptysBio Correlation, AnaptysBio Volatility and AnaptysBio Alpha and Beta module to complement your research on AnaptysBio. For information on how to trade AnaptysBio Stock refer to our How to Trade AnaptysBio Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
AnaptysBio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.